Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-24

Clinical Trial Update: Bezafibrate Plus Berberine in Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial of bezafibrate plus berberine in mixed dyslipidemia completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine (berberine)
  • Bezafibrate (bezafibrate)

Snippet

Sponsor: University of Guadalajara | Conditions: Mixed Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2023-02-24